FTI Consulting Reports Mixed Q1 2026 Results with Revenue Growth, Profit Decline, and New $300M Term Loan
summarizeSummary
FTI Consulting reported mixed Q1 2026 results with strong revenue growth but a decline in net income and Adjusted EBITDA, alongside a significant increase in long-term debt from a new $300 million term loan.
check_boxKey Events
-
Q1 2026 Revenue Growth
Revenues increased 9.5% year-over-year to $983.3 million for the three months ended March 31, 2026.
-
Profitability Decline
Net income decreased 6.8% to $57.6 million, and Adjusted EBITDA fell 15.9% to $96.8 million compared to the prior year quarter.
-
EPS Increase Driven by Buybacks
Diluted EPS rose 9.2% to $1.90, primarily due to a reduction in weighted average shares outstanding from ongoing share repurchases.
-
New $300M Incremental Term Loan
The company secured a new $300 million Incremental Term Loan, increasing long-term debt from $365.0 million to $754.3 million.
auto_awesomeAnalysis
The Q1 2026 filing presents a mixed financial picture for FTI Consulting. While the company achieved a solid 9.5% year-over-year revenue growth, profitability metrics such as net income and Adjusted EBITDA declined. The increase in diluted EPS was primarily driven by share repurchases, which reduced the weighted average share count, rather than an increase in net income. A significant development is the securing of a new $300 million Incremental Term Loan, which nearly doubled the company's long-term debt. This capital infusion improves liquidity but also led to a notable increase in interest expense. Positively, the company reported no special charges in Q1 2026, compared to $25.3 million in the prior year, and net cash used in operating activities significantly improved. Investors should monitor the impact of increased debt on future interest expenses and the company's ability to translate revenue growth into improved profitability.
At the time of this filing, FCN was trading at $188.46 on NYSE in the Trade & Services sector, with a market capitalization of approximately $5.4B. The 52-week trading range was $149.31 to $189.30. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.